Immunomedics (Immunomedics) 6-Month Price Index : N/A (As of May. 06, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Immunomedics 6-Month Price Index?

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2024-05-06), Immunomedics's 6-Month Price Index is N/A.

Competitive Comparison of Immunomedics's 6-Month Price Index

For the Biotechnology subindustry, Immunomedics's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunomedics (NAS:IMMU) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index

Current Share Price

Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunomedics (NAS:IMMU) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Immunomedics 6-Month Price Index Related Terms

Thank you for viewing the detailed overview of Immunomedics's 6-Month Price Index provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunomedics (Immunomedics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunomedics Inc (NAS:IMMU) » Definitions » 6-Month Price Index

Comparable Companies

Traded in Other Exchanges

N/A

Address

300 The American Road, Morris Plains, NJ, USA, 07950

Website

http://www.immunomedics.com

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

Executives

Scott A Canute	director	FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
Barbara Gayle Duncan	director	C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES STREET, NEW YORK NY 10013
Peter Barton Hutt	director
Charles M Baum	director	C/O MIRATI THERAPEUTICS INC., 9393 TOWNE CENTRE DRIVE, STE 200, SAN DIEGO CA 92121
Khalid Islam	director	C/O IMMUNOMEDICS, INC., 300 THE AMERICAN ROAD, MORRIS PLAINS NJ 07950
Venbio Select Advisor Llc	director, 10 percent owner, other: See Remarks	110 GREENE STREET, SUITE 800, NEW YORK NY 10012
Behzad Aghazadeh	director, 10 percent owner, other: See Remarks	C/O AVORO CAPITAL ADVISORS LLC, 110 GREENE STREET, SUITE 800, NEW YORK NY 10012
Robert Azelby	director	307 WESTLAKE AVE. NORTH, STE 300, SEATTLE WA 98109
Harout Semerjian	director, officer: President and CEO	300 THE AMERICAN ROAD, C/O IMMUNOMEDICS, INC., MORRIS PLAINS NJ 07950
Kurt J. Andrews	officer: Chief Human Resources Officer	C/O AMICUS THERAPEUTICS, INC., 1 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Bryan Ball	officer: Chief Quality Officer	300 THE AMERICAN ROAD, MORRIS PLAINS NJ 07950
Jared Freedberg	officer: General Counsel	300 THE AMERICAN ROAD, MORRIS PLAINS NJ 07950
Usama Malik	officer: Chief Business Officer & CFO	300 THE AMERICAN WAY MORRIS PLAINS NJ 07950
Brendan Delaney	officer: Chief Commerical Officer	300 THE AMERICAN WAY, MORRIS PLAINS NJ 07950
Lorettta M Itri	officer: Chief Medical Officer